Iovance Biotherapeutics Inc (NASDAQ:IOVA)
| 29.20 BATS BZX Real-Time Price As of 1:44pm ET |  -0.17 / -0.58%Today’s Change | 24.67 Today|||52-Week Range 54.21 | -37.07% Year-to-Date |
Latest IOVA News | Press Releases
| This Big Leap in Cancer Treatment Could Change the Landscape Apr 01 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 29.37 |
| Today’s open | 29.47 |
| Day’s range | 28.94 - 30.21 |
| Volume | 97,509 |
| Average volume (3 months) | 1,680,684 |
| Market cap | $4.6B |
Data as of 1:44pm ET, 04/13/2021
Growth & Valuation
| Earnings growth (last year) | -18.13% |
| Earnings growth (this year) | -8.60% |
| Earnings growth (next 5 years) | -19.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 6.94 |
Competitors
| ---- | ||
| ALLOAllogene Therapeutic... | +0.44 | +1.49% |
| EBSEmergent BioSolution... | -3.94 | -5.19% |
| NTLAIntellia Therapeutic... | +0.14 | +0.20% |
Data as of 1:44pm ET, 04/13/2021
Financials
| Next reporting date | May 11, 2021 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$259.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Carlos, California |
Forecasts
